CoMFA study on selective human ß3-adrenoceptor agonists

CoMFA study on selective human ß3-adrenoceptor agonists

Bibliographic Details
Main Authors:	P. Senthil Kumar, Prasad V. Bharatam
Format:	Article
Language:	English
Published:	Arkat USA, Inc. 2005-04-01
Series:	ARKIVOC
Online Access:	https://www.arkat-usa.org/arkivoc-journal/browse-arkivoc/ark.5550190.0006.d06

Similar Items

QSAR-3D/CoMFA em compostos imídicos com atividade antinociceptiva
by: Maria Elena Walter, et al.
Published: (2013-01-01)

2D-QSAR and CoMFA Models for Antitubercular Activity of Scalarane-Type Sesterterpenes
by: Suriyan Thengyai, et al.
Published: (2022-08-01)

CoMFA, Molecular Docking and Molecular Dynamics Studies on Cycloguanil Analogues as Potent Antimalarial Agents
by: Isman Kurniawan, et al.
Published: (2020-09-01)

QSAR studies of angiotensin converting enzyme inhibitors using CoMFA, CoMSIA and molecular docking
by: Tong Jian-Bo, et al.
Published: (2021-01-01)

Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles
by: Marcos Lorca, et al.
Published: (2018-05-01)

QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking
by: Hao Ding, et al.
Published: (2024-03-01)

2D-SAR, Topomer CoMFA and molecular docking studies on avian influenza neuraminidase inhibitors
by: Bing Niu, et al.
Published: (2019-01-01)

3D-QSAR/CoMFA-Based Structure-Affinity/Selectivity Relationships of Aminoalkylindoles in the Cannabinoid CB1 and CB2 Receptors
by: Jaime Mella-Raipán, et al.
Published: (2014-03-01)

CoMFA, CoMSIA and Eigenvalue Analysis on Dibenzodioxepinone and Dibenzodioxocinone Derivatives as Cholesteryl Ester Transfer Protein Inhibitors
by: Mao-sheng Cheng, et al.
Published: (2008-08-01)

Design and synthesis of a novel mPGES-1 lead inhibitor guided by 3D-QSAR CoMFA
by: Mohd F. F., Mohd Aluwi, et al.
Published: (2019)

Structural Insights on Hyp-Gly-Containing Peptides as Antiplatelet Compounds through Topomer CoMFA and CoMSIA Analysis
by: Yijie Yang, et al.
Published: (2023-02-01)

Estimating antiwear properties of esters as potential lubricant-based oils using QSTR models with CoMFA and CoMSIA
by: Zhan Wang, et al.
Published: (2017-12-01)

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches
by: Linfeng Zheng, et al.
Published: (2022-10-01)

High Throughput Screening and QSAR-3D/CoMFA: Useful Tools to Design Predictive Models of Substrate Specificity for BiocatalystsÃ¢Â€
by: J. V. Sinisterra, et al.
Published: (2004-07-01)

Structure-Activity Relationship Studies Based on 3D-QSAR CoMFA/CoMSIA for Thieno-Pyrimidine Derivatives as Triple Negative Breast Cancer Inhibitors
by: Jin-Hee Kim, et al.
Published: (2022-11-01)

Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities.
by: Richard D Cramer
Published: (2015-01-01)

A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
by: Yang Wang, et al.
Published: (2013-08-01)

3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models
by: Swetha Gade, et al.
Published: (2012-01-01)

Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands
by: Sara Guariento, et al.
Published: (2017-01-01)

Establishment of a CoMFA Model Based on the Combined Activity of Bioconcentration, Long-Range Transport, and Highest Infrared Signal Intensity and Molecular Design of Environmentally Friendly PBB Derivatives
by: Luze Yang, et al.
Published: (2021-01-01)

Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) Studies on α1A-Adrenergic Receptor Antagonists Based on Pharmacophore Molecular Alignment
by: Mu Yuan, et al.
Published: (2011-10-01)

CoMFA and docking study of 2,N6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as novel PfDHFR enzyme inhibitors for antimalarial activity
by: Pritam N. Dube, et al.
Published: (2014-06-01)

Three-dimensional quantitative structure activity relationship (QSAR) of cytotoxic active 3,5-diaryl-4,5-dihydropyrazole analogs: a comparative molecular field analysis (CoMFA) revisited study
by: Hamad Elgazwy Abdel-Sattar S, et al.
Published: (2012-05-01)

Guyanese comfa: arts of imagination
by: Asantewa, Michelle
Published: (2009)

Investigations into the presence of functional ß1, ß2 and ß3-adrenoceptors in urothelium and detrusor of human bladder
by: Pradeep Tyagi, et al.
Published: (2009-02-01)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2022-10-01)

A Selective Pharmacophore Model for β2-Adrenoceptor Agonists
by: Mao-Sheng Cheng, et al.
Published: (2009-11-01)

Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.
by: Nazanin Ghazanfari, et al.
Published: (2014-01-01)

Electrophysiological Remodeling: Cardiac T-Tubules and ß-Adrenoceptors
by: Peter T. Wright, et al.
Published: (2021-09-01)

Challenges in β-adrenoceptor agonist drug development
by: Jonathan R. S. Arch
Published: (2011-04-01)

Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function.
by: Green, A, et al.
Published: (1984)

Potent and selective α1A adrenoceptor partial agonists—Novel imidazole frameworks
by: Whitlock, G, et al.
Published: (2009)

Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density
by: Shota Yamamoto, et al.
Published: (2023-01-01)

On the Site and Mechanism of Action of β-Adrenoceptor Agonists in the Bladder
by: Karl Erik Andersson
Published: (2017-03-01)

Paradoxical bronchoconstriction caused by β2-adrenoceptor agonists
by: Khadija Ayed, et al.
Published: (2020-10-01)

First Direct Isolation of Stable α-Form Crystals of Mirabegron, a Selective β3–Adrenoceptor Agonist
by: Vijayavitthal T. Mathad, et al.
Published: (2017-06-01)

BRONCHODILATOR AND TOCOLYTIC FEATURES OF β<sub>2</sub>-ADRENOCEPTOR AGONISTS
by: S. Ya. Skachilova, et al.
Published: (2019-01-01)

The α2-Adrenoceptor Agonist Dexmedetomidine in Current Sedation Practice
by: I. A. Kozlov
Published: (2013-04-01)

A Clinician’s Perspective on the Mechanism of β-Adrenoceptor Agonists in the Bladder
by: Tack Lee
Published: (2017-03-01)

Pharmacological Profile of KUL-7211, a Selective -Adrenoceptor Agonist, in Isolated Ureteral Smooth Muscle
by: Yoshitaka Tomiyama, et al.
Published: (2003-01-01)